Back
Quince Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
QNCX
Quince Therapeutics, Inc.
Last Price:
$3.53
Seasonality Move:
-7.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QNCX is experiencing slight buying pressure.
Quince Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.63 | Sell |
| 20-day SMA: | 3.72 | Sell |
| 50-day SMA: | 2.61 | Buy |
| 200-day SMA: | 1.73 | Buy |
| 8-day EMA: | 2.99 | Buy |
| 20-day EMA: | 1.82 | Buy |
| 50-day EMA: | 0.88 | Buy |
| 200-day EMA: | 0.24 | Buy |
Quince Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 56.13 | Buy |
| Chaikin Money Flow: | 111253 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.92 - 4.06) | Buy |
| Bollinger Bands (100): | (1.3 - 2.98) | Buy |
Quince Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Quince Therapeutics, Inc. Stock
Is Quince Therapeutics, Inc. Stock a Buy?
-
Quince Therapeutics, Inc. share price is 3.56 while QNCX 8-day simple moving average is 3.63, which is a Sell signal.
-
The stock price of QNCX is 3.56 while Quince Therapeutics, Inc. 20-day SMA is 3.72, which makes it a Sell.
-
Quince Therapeutics, Inc. 50-day simple moving average is 2.61 while QNCX share price is 3.56, making it a Buy technically.
-
QNCX stock price is 3.56 and Quince Therapeutics, Inc. 200-day simple moving average is 1.73, creating a Buy signal.
QNCX Technical Analysis vs Fundamental Analysis
Buy
53
Quince Therapeutics, Inc. (QNCX)
is a Buy
Is Quince Therapeutics, Inc. a Buy or a Sell?
-
Quince Therapeutics, Inc. stock is rated a BuyThe current Quince Therapeutics, Inc. [QNCX] share price is $3.56. The Score for QNCX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Quince Therapeutics, Inc. Stock Info
Market Cap:
198.2M
Price in USD:
3.56
Share Volume:
388.3K
Quince Therapeutics, Inc. 52-Week Range
52-Week High:
4.55
52-Week Low:
0.72
Buy
53
Quince Therapeutics, Inc. (QNCX)
is a Buy
Quince Therapeutics, Inc. Share Price Forecast
-
What is the Quince Therapeutics, Inc. stock price today?The Quince Therapeutics, Inc. stock price is 3.56 USD today.
-
Will QNCX stock go up or go down?Quince Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Quince Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Quince Therapeutics, Inc. is not overvalued.
Is Quince Therapeutics, Inc. Stock a Buy?
-
Quince Therapeutics, Inc. share price is 3.56 while QNCX 8-day exponential moving average is 2.99, which is a Buy signal.
-
The stock price of QNCX is 3.56 while Quince Therapeutics, Inc. 20-day EMA is 1.82, which makes it a Buy.
-
Quince Therapeutics, Inc. 50-day exponential moving average is 0.88 while QNCX share price is 3.56, making it a Buy technically.
-
QNCX stock price is 3.56 and Quince Therapeutics, Inc. 200-day simple moving average is 0.24, creating a Buy signal.
Fundamental Analysis of Quince Therapeutics, Inc.
Is Quince Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.36 per share.
Technical Analysis of Quince Therapeutics, Inc.
Should I short Quince Therapeutics, Inc. stock?
-
QNCX Moving Average Covergence Divergence (MACD) indicator is 0.99, suggesting Quince Therapeutics, Inc. is a Buy
-
Quince Therapeutics, Inc. Relative Strength Index (RSI) is 56.13, which suggest Quince Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Quince Therapeutics, Inc. is (2.92 - 4.06), which suggest Quince Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Quince Therapeutics, Inc. is (1.3 - 2.98), which suggest Quince Therapeutics, Inc. is a Buy
* Quince Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.